BridgeBio Oncology Therapeutics, Inc (BBOT)

Last Closing Price: 12.29 (2026-01-02)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BridgeBio Oncology Therapeutics, Inc (BBOT) Revenue data is not available.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
Revenue
--
$-44.76M
--
--
$49.18M
$-49.18M
$4.42M
$-44.76M
$-44.76M
$-44.76M
$-44.76M
$-44.76M
$-44.76M
$-49.18M
$-49.18M
43.49M
43.49M
$-1.03
$-1.03
Balance Sheet Financials
$476.01M
$0.83M
$8.78M
$484.79M
$35.71M
--
$2.38M
$38.09M
$446.70M
$446.70M
$446.70M
79.20M
Cash Flow Statement Financials
$-71.66M
$65.56M
$383.99M
$30.98M
$408.87M
$377.89M
$2.93M
--
--
Fundamental Metrics & Ratios
13.33
--
--
--
--
--
--
--
--
--
--
$-72.19M
--
--
--
--
--
--
--
-10.02%
-10.02%
-9.23%
-10.02%
$5.64
$-1.66
$-1.65